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AntifungalAbstract Design and discovery of novel antifungal compounds is the need of time, more than ever
before due to the unavailability of effective antifungal therapy to treat resistant fungal infections.
Due to morphological and functional similarities of fungi both with plant cell and human cell,
the search for effective targets leading to speciﬁcity of antifungal drug action becomes all that more
difﬁcult. For the design of novel antifungal agents, it is necessary to comprehend the life cycle, mor-
phology, metabolic pathways, etc. of fungi scientiﬁcally and systematically to identify critical tar-
gets for antifungal drug design. Fungi speciﬁc riboﬂavin metabolism involves lumazine synthase
catalyzed synthesis of 6,7-dimethyl-8-D-ribityl lumazine which is converted to riboﬂavin by a ribo-
ﬂavin synthase. Therefore lumazine synthase has been targeted for the design of newer antifungal
agents. The pharmacophore modeling and 3D QSAR studies were carried out on 32 N-substituted
aryl amine derivatives as fungal lumazine synthase inhibitors. The selected model of 3D QSAR
showed positive correlation of electronic descriptors with antifungal activity while steric and hydro-
phobic descriptors showed negative correlation with antifungal activity. The resulting model exhib-
ited good q2 and r2 values up to 0.9109 and 0.845 respectively.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
In recent years the fungal infections have become a major cause
of death in patients suffering fromdisease like AIDS (Morguno-
va et al., 2007). Themain classes of antifungal drugs which are in
market now are having problems like high risk of toxicity, devel-
opment of resistance and pharmacokinetic deﬁciencies (Cush-
man, 1998; Graybill, 1996). A detailed study of biochemical
constituents of fungal cell wall, cytoplasmic membrane and
DNA and protein synthesis of fungal cell, signal transduction
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the newpotential targets for antifungal development (Cushman,
2005; Leonor, 2003; Urbina, 2000). Fungi can synthesize their
own riboﬂavin, so design, synthesis and screening of inhibitors
of lumazine synthase have been targeted to develop effective
antifungals. 3D QSAR studies correlate the physiochemical
properties in the form of 3D descriptors with biological activity
which can be utilized to optimize the molecules with better bio-
logical activity (Bhatia et al.,2009a,b; 2010a,b) We have already
reported the design of novel N-substituted aryl amine deriva-
tives as potential inhibitors of lumazine synthase (Bhatia,
2010c). In continuation of our previous work, we are reporting
the 3D QSAR and pharmacophore modeling of N-substituted
aryl amine derivatives.
2. Materials and methods
2.1. Three dimensional QSAR analysis
2.1.1. Ligand preparation
The structure of the C–N bond was used as the template to
build the molecules in the dataset in Vlife MDS 3.5 (Bhatia
et al., 2009a,b; 2010a,b). The ligand geometries were optimized
by energy minimization using MMFF94 force ﬁeld and Gastei-
ger-Marsili charges for the atoms, till a gradient of 0.001 kcal/
mol/A˚ was reached, maintaining the template structure rigid
during the minimization.
2.1.2. Molecular alignment
The molecules of the dataset were aligned by the atom-ﬁt tech-
nique, using atoms common to the structure of 4-ﬂuoro-N-
[1-(4-chlorophenyl) but-3-en-1-yl] aniline. The virtually mostFigure 1 Field points for selected QSAR models. The ﬁgure indicate
hydrophobic (yellow), electric (blue) features which are required for aactive lead was selected as a template for alignment of the mol-
ecules. The alignment of all the molecules on the template is
shown in Fig. 1.
2.1.3. Descriptor calculation
Like many 3D QSAR methods, a suitable alignment of a given
set of molecules was performed using the Vlife MDS 3.5
Engine. This was followed by generation of a common rectan-
gular grid around the molecules. The hydrophilic, steric and
electrostatic interaction energies are computed at the lattice
points of the grid using a methyl probe of charge +1. These
interaction energy values are considered for relationship gener-
ation and utilized as descriptors to decide nearness between
molecules. The term descriptor is utilized in the following dis-
cussion to indicate ﬁeld values at the lattice points. For getting
reliable results, dataset having typically 5 times as many data
points (molecules) as independent variables (descriptors) are
required, so the ﬁve descriptors were selected in the ﬁnal equa-
tion from calculated 2000 descriptors.
2.1.4. Data set
The dataset was divided into a training set (27 molecules,
Table 1) and a test set (05 molecules, Table 1) on the basis
of chemical and biological diversity using the random selection
method for generation of the training and test set data. The
molar Inhibitory concentration (pMIC) values for antifungal
activity were used for the present 3D QSAR study.
2.2. Full search multiple linear regression method
Relationship between independent and dependent variables
(3D ﬁelds and biological activities, respectively) was determineds the ﬁeld points for selected QSAR models, that is steric (green),
ctivity.
Table 1 Synthesized molecules utilized in QSAR study.

























Sr. No. R0 R00 R00 0
1 4-Dimethylamino benzaldehyde 2-Amino pyridine Allyl bromide
2 4-Dimethyl amino benzaldehyde 3-Nitro aniline Allyl bromide
3 4-Dimethyl amino benzaldehyde 4-Fluoro aniline Allyl bromide
4 4-Dimethyl amino benzaldehyde 1-Naphthyl amine Allyl bromide
5 4-Methoxy benzaldehyde 2-Amino pyridine Allyl bromide
6 4-Methoxy benzaldehyde 3-Nitro aniline Allyl bromide
7 4-Methoxy benzaldehyde 4-Fluro aniline Allyl bromide
8 4-Methoxy benzaldehyde 1-Naphthyl amine Allyl bromide
9 4-Chloro benzaldehyde 2-Amino pyridine Allyl bromide
10 4-Chloro benzaldehyde 3-Nitro aniline Allyl bromide
11 4-Chloro benzaldehyde 4-Fluro aniline Allyl bromide
12 4-Chloro benzaldehyde 1-Naphthyl amine Allyl bromide
13 Indole-3-carboxyaldehyde 2-Amino pyridine Allyl bromide
14 Indole-3-carboxyaldehyde 3-Nitro aniline Allyl bromide
15 Indole-3-carboxyaldehyde 4-Fluro aniline Allyl bromide
16 Indole-3-carboxyaldehyde 1-Naphthyl amine Allyl bromide
17 4-Dimethyl amino benzaldehyde 2-Amino pyridine Cinnamoyl chloride
18 4-Dimethyl amino benzaldehyde 3-Nitro aniline Cinnamoyl chloride
19 4-Dimethyl amino benzaldehyde 4-Fluro aniline Cinnamoyl chloride
20 4-Dimethyl amino benzaldehyde 1-Naphthyl amine Cinnamoyl chloride
21 4-Methoxy benzaldehyde 2-Amino pyridine Cinnamoyl chloride
22 4-Methoxy benzaldehyde 3-Nitro aniline Cinnamoyl chloride
23 4-Methoxy benzaldehyde 4-Fluro aniline Cinnamoyl chloride
24 4-Methoxy benzaldehyde 1-Naphthyl amine Cinnamoyl chloride
25 4-Chloro benzaldehyde 2-Amino pyridine Cinnamoyl chloride
26 4-Chloro benzaldehyde 3-Nitro aniline Cinnamoyl chloride
27 4-Chloro benzaldehyde 4-Fluro aniline Cinnamoyl chloride
28 4-Chloro benzaldehyde 1-Naphthyl amine Cinnamoyl chloride
29 Indole-3-carboxyaldehyde 2-Amino pyridine Cinnamoyl chloride
30 Indole-3-carboxyaldehyde 3-Nitro aniline Cinnamoyl chloride
31 Indole-3-carboxyaldehyde 4-Fluro aniline Cinnamoyl chloride
32 Indole-3-carboxyaldehyde 1-Naphthyl amine Cinnamoyl chloride
S102 M.S. Bhatia et al.statistically using regression analysis. The quality of ﬁt for a
regression equation was assessed using various statistical
parameters like r2, q2 (F test). Models showing q2 below 0.6
were discarded. The selected models for antifungal activity are
shown in Table 1.
2.3. Activity prediction
To systematically assess a QSAR model, a reliable validation is
required. Usually, a QSAR model is evaluated by the predic-
tive results for the given dataset. Selected models having r2
above 0.7 were checked for their external predictivity. The
observed and the predicted values for antifungal activity are
shown in Table 2.
2.4. Pharmacophore modeling
This pharmacophore modeling was carried out in the mol sign
module of Vlife MDS 3.5 software. A series of lumazine syn-thase inhibitors was ﬁrst aligned on the active molecule. Align-
ment of small organic molecules is one of the important tasks
in drug design and bioactivity prediction. A pharmacophore
model is a set of three dimensional features that are necessary
for bioactive ligands. Thus, it makes logical sense to align mol-
ecules based on features that are responsible for bioactivity,
the number indicates the minimum number of pharmacophore
features generated for an alignment is taken as 4 and the toler-
ance is kept at 10 A˚. The max distance allowed between two
features is placed at 10 A˚.
3. Results and discussion
3.1. Results
To obtain the effects of the structural parameters of the
N-substituted aryl amine derivatives on antifungal activity,
3D QSAR analysis was performed by using various molecular
descriptors which were correlated with the negative logarithm
Table 2 Observed and predicted activity by QSAR equation
along with residuals.
Compound code Observed activity Predicted activity Residuals
Training set
1 4.328 4.378 0.05
10 4.387 4.382 0.005
11 4.301 4.308 0.007
12 4.387 4.347 0.04
13 4.319 4.396 0.077
4 4.387 4.412 0.025
15 4.553 4.53 0.023
16 4.301 4.29 0.011
18 4.509 4.488 0.021
19 4.357 4.772 0.415
2 4.398 4.34 0.058
21 4.638 4.701 0.063
22 4.398 4.423 0.025
23 4.469 4.451 0.018
24 4.276 4.325 0.049
25 4.444 4.506 0.062
26 4.678 4.603 0.075
28 4.409 4.701 0.292
3 4.553 4.451 0.102
30 4.284 4.325 0.041
31 4.469 4.506 0.037
32 4.409 4.603 0.194
4 4.481 4.449 0.032
5 4.31 4.34 0.03
6 4.352 4.178 0.174
7 4.337 4.385 0.048
8 4.292 4.269 0.023
Test set
17 4.509 4.793 0.284
20 4.77 4.264 0.506
27 4.244 4.617 0.373
29 4.155 4.423 0.268
9 4.398 4.541 0.143
Figure 2 Correlation plot between observed activity and pre-
dicted activity. The ﬁgure indicates the correlation plot between
predicted activity and observed activity which shows the signiﬁ-
cance of QSAR equation in predicting the activity.
Figure 3 Pharmacophore for synthesized molecules. The ﬁgure
indicates the pharmacophoric features like hydrogen bond donor
(magenta) and hydrophobic (orange) which are required for
activity.
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which only one was selected based on correlation coefﬁcient
and different statistical parameters and are given in Table 3.
The square of correlation coefﬁcient (r2 = 0.9109), square of
correlation coefﬁcient for cross-validation (q2 = 0.8451) and
the F test (42.9425) were employed to judge the validation of
regression equation observed against Candida albicans. The
electronic descriptors which measured as 0.0921 E_1538 and
0.0249 E_464 (blue) contribute positively for anti-fungal activ-
ity while the electronic descriptor measured as 0.0159 E_2109,
steric descriptor measured as 0.0055 S_1364 (green) and hydro-
phobic descriptor measured as 0.3286 H_776 (yellow) contrib-
ute negatively for anti-fungal activity as shown in Figs. 1 and 2.
3.2. Pharmacophore modeling study
A set of pharmacophore hypothesis was generated using the
mole signmodule of Vlife 3.5. Each hypothesis contains the fourTable 3 Selected QSAR equations along with statistical parameter
QSAR model N
pMIC= 4.7903  0.0159 E_21090.0055 S_13640.3286
H_776 + 0.0921 E_1538 + 0.0249 E_464.
32features like hydrogen bond donor, hydrogen bond acceptor,
hydrophobic, and aliphatic that are common. The pharmaco-
phore models were validated by using the pharmacophoric
search for reported lumazine synthase inhibitors. The structures
of the reported lumazine synthase which are in clinical use are
used to predict the pharmacophore model for them and these
features are compared with the training set and designed
molecules to validate the results as shown in Fig. 3. The results
of the pharmacophoric search can give the following results.
The important features that are required for the lumazine
synthase inhibitory activity are the hydrogen bond donor (buff)s employed for model selection.
r2 q2 F value Predicted r2
0.9109 0.8451 42.942 0.8650
S104 M.S. Bhatia et al.and hydrophobic interaction groups (magenta). The introduc-
tion of groups which are fascinating these parameters may in-
crease the lumazine synthase inhibitory activity.
4. Conclusion
The 3D QSAR statistical model described in this work shows
both good internal and external consistencies. By 3D QSAR
studies of steric and electrostatic contour maps we can conclude
that electronegative groups surrounding the N-substituent are
required for antifungal activity. In addition, the favorable steric
contours suggest that aromatic bulky groups at the pyridine
ring moiety may increase ligand potency. The 3D QSAR mod-
els should be useful for the design of new structurally related
potential lumazine synthase inhibitors.
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